会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Methods for the treatment of bone resorption disorders, including
osteoporosis
    • 治疗骨吸收障碍的方法,包括骨质疏松症
    • US5830850A
    • 1998-11-03
    • US704473
    • 1996-08-28
    • Bruce D. GelbHarold ChapmanRobert J. Desnick
    • Bruce D. GelbHarold ChapmanRobert J. Desnick
    • A61K45/00A61K31/00A61P19/08A61P19/10A61P43/00A61K48/00
    • A61K31/00
    • The present invention relates to methods and compositions for the amelioration of symptoms caused by bone resorption disorders, including but not limited to osteoporosis, arthritides and periodontal disease, and damage caused by macrophage-mediated inflammatory processes. In one embodiment, the methods and compositions of the invention include methods and compositions for the specific inhibition of cathepsin K activity. In an additional embodiment, the methods and compositions of the invention include methods and compositions for the specific inhibition of cathepsin K activity coupled with specific inhibition of at least a second activity involved in the bone resorption and/or macrophage-mediated inflammatory processes. In a particular embodiment, the methods and compositions of the invention include methods and compositions for the specific inhibition of cathepsin K and cathepsin S activity.
    • 本发明涉及用于改善由骨吸收障碍引起的症状的方法和组合物,包括但不限于骨质疏松症,关节炎和牙周病以及由巨噬细胞介导的炎性过程引起的损伤。 在一个实施方案中,本发明的方法和组合物包括用于特异性抑制组织蛋白酶K活性的方法和组合物。 在另外的实施方案中,本发明的方法和组合物包括用于特异性抑制组织蛋白酶K活性的方法和组合物,以及参与骨吸收和/或巨噬细胞介导的炎症过程的至少第二活性的特异性抑制。 在一个具体实施方案中,本发明的方法和组合物包括用于特异性抑制组织蛋白酶K和组织蛋白酶S活性的方法和组合物。